Business Daily Media


Business News

Catalent Pharma Solutions appoints Stephen Vanni as General Manager



Somerset, N.J. – July 5, 2016
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the appointment of Stephen Vanni as General Manager of the company’s Braeside facility in Melbourne, Australia.

Catalent’s 331,055 sq. ft. Braeside facility is one of the company’s key strategic hubs within the Asia Pacific region, and has both softgel and solid dose manufacturing operations.

Mr. Vanni joins Catalent from Aspen Pharma, where he was Southern Region Plant Manager, based at the company’s Dandenong facility, and had full responsibility over the plant’s safety, quality and regulatory compliance, as well financial oversight on investment and revenue.

Stephen will play a central role in the strategic growth of Catalent’s business within Australia and the greater Asia-Pacific region,” commented Mark Bisset, President of Catalent Asia Pacific. “His insight and experience will be invaluable to our growing Executive Leadership team as we look to continue to expand our reach within the consumer health and over the counter formulations space in this marketplace.”

Mr. Vanni has over 20 years’ experience within the chemical and food production industries, and has previously worked for ICI Australia, and Bristol-Myers Squibb. He holds a MSc. in Chemistry from Monash University, Melbourne.

In 2015, Catalent announced the acquisition of a facility in Cromer, New South Wales, from PharmaPak, to offer primary and secondary packaging of oral pharmaceutical dose forms. This facility, alongside Braeside, supports Catalent’s integrated supply to customers across Australia, New Zealand and the Asia Pacific region.

About Catalent

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents, and in fiscal 2015 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit www.catalent.com

 

More products. Better treatments. Reliably supplied.™

Business Daily Media Business Development

3 Ways To Get More Business From Traveling Retirees

If you work in the tourism industry, you’ve likely taken a huge hit in the last year. However, with vaccines being distributed around the world and people being more willing and able...

News Co Media - avatar News Co Media

6 International Expansion Strategies to Achieve Global Competitive Edge

Business growth has always been the number one priority of every business. Growing the business and expanding it from one city to a statewide local market and then globally is the drea...

Eliza Jeffrey - avatar Eliza Jeffrey

Pacific Island nations next after New Zealand for travel bubble inclusion

Following the Australian Chief Medical Officer Professor Paul Kelly’s latest comments indicating the Pacific Island nations being next after New Zealand for travel bubble inclusion, ...

News Co - avatar News Co

Should You Head Southwest if You Don't Like the Cold?

Snowbirds and young spirits alike flock to states like Arizona and Texas the moment things up north start to dip below forty degrees. These states never seem to get truly cold, and pop...

News Co - avatar News Co

Writers Wanted



News Co Media

Content & Technology Connecting Global Audiences

More Information - Less Opinion